Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 6 institutions in 1 country.
João Alfredo MoraesLaboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0002-8563-6432
Genilson RodriguesLaboratório de Farmacologia Celular e Molecular, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551-030, Brazil.
Daniel Guimarães-BastosLaboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil.
Vany Nascimento-SilvaLaboratório de Farmacologia Celular e Molecular, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551-030, Brazil.
Erik SvensjöInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0002-7356-1787
Mariana Renovato-MartinsLaborotário de Imunologia e Metabolismo, Universidade Federal Fluminense, Niterói 22410-201, Brazil.ORCID 0000-0002-9860-5272
Markus BergerLaboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-003, Brazil.ORCID 0000-0001-7670-2584
Jorge GuimarãesLaboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-003, Brazil.ORCID 0000-0002-4898-071X
Christina Barja-FidalgoLaboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0002-1917-4401
Universidade Federal do Rio de Janeiro · BRUniversidade do Estado do Rio de Janeiro · BRHospital de Clínicas de Porto Alegre · BRUniversidade Federal do Estado do Rio de Janeiro · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Federal Fluminense · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The significant incidence of deforestation in South America culminates in the contact of humans with typical forests species. Among these species, one may highlight
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.